PupilScan

Curated by Signal

Provider of mobile app to diagnose drug overdose with eye scan

Overview

PupilScan is a provider of mobile app to diagnose drug overdose with eye scan. The app captures involuntary pupillary light reflex (PLR) and captures pupillary data which is then uploaded cloud-based toxicological analysis engine to determine potential overdose.

Key facts

Founded: 2017
Headquarters: Princeton, United States
Stage: Sign up to view
Industry: Health Technology

Business model

GTM channel: Sign up to view

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Leda Health
Provider of wide range of services for sexual assault
Health TechnologyNew York City, United States
Fittbe
App for Pilates training
Health TechnologyIssaquah, United States
Helix Life Science
Provider of drug development collaboration platform
Health TechnologySan Francisco, United States

About PupilScan

What does PupilScan do?

PupilScan is a provider of mobile app to diagnose drug overdose with eye scan.

Where is PupilScan headquartered?

PupilScan is headquartered in Princeton, United States.

When was PupilScan founded?

PupilScan was founded in 2017.

Which sector is PupilScan in?

PupilScan operates in Health Technology.

Who are PupilScan's competitors?

Companies similar to PupilScan include Leda Health, Fittbe, and Helix Life Science.